BASEL, Switzerland, June 01, 2026--(BUSINESS WIRE)--Ascensia Diabetes Care, a global diabetes care company and subsidiary of PHC Holdings Corporation (TSE 6523), today announced the launch of ...
Ascensia Diabetes Care Expands CONTOUR® Portfolio with CONTOUR®COMFORT Pen Needles to Bring Greater Stability and Control to the Everyday Injection Experience Ascensia Diabetes Care, a global diabetes ...
“With CONTOUR COMFORT pen needles, we are addressing a very practical and important part of diabetes management,” said Peter Bodlund, President and Chief Executive Officer of Ascensia Diabetes Care.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results